小儿大叶性肺炎肺炎支原体肺炎合并腺病毒感染的临床分析。

IF 3 3区 医学 Q2 INFECTIOUS DISEASES
Meiying Piao, Na Liu, Fanyang Meng, Hang Liang
{"title":"小儿大叶性肺炎肺炎支原体肺炎合并腺病毒感染的临床分析。","authors":"Meiying Piao, Na Liu, Fanyang Meng, Hang Liang","doi":"10.1007/s10096-025-05194-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Mycoplasma pneumoniae (MP) is a major pathogen that causes community-acquired pneumonia in children with a high rate of co-infection. Human adenovirus (HAdV) is a common co-infecting pathogen. This study aimed to analyze the clinical characteristics of children with lobar pneumonia caused by co-infection with MP and HAdV, and to investigate the correlation between the MP mutation sequence ratio (mutation depth/MP count) and HAdV sequence count with disease severity, thus providing evidence for clinical diagnosis and treatment.</p><p><strong>Methods: </strong>Children with MP-infected lobar pneumonia hospitalized in the Department of Pediatric Respiratory Medicine at the First Hospital of Jilin University from September to November 2023 were enrolled in this study and divided into MP and MP + HAdV groups. Clinical manifestations, laboratory examinations, and treatments were compared between the two groups. Correlations of the MP mutation sequence ratio and HAdV sequence count with clinical manifestations, laboratory examinations, and treatments were analyzed.</p><p><strong>Results: </strong>A total of 154 children with MP lobar pneumonia were included, with 96 cases in the MP group and 58 cases in the MP + HAdV group. The results showed that the MP + HAdV group had a longer total disease duration, fever duration, intravenous anti-MP drug administration duration, and systemic corticosteroid application duration, with a higher proportion of intravenous immunoglobulin use. The MP group had higher CRP levels and a higher incidence of pulmonary necrosis. After 10 days of treatment, the MP group showed better improvement in the pneumonia volume than the MP + HAdV group. There were no significant differences between the two groups in the length of hospital stay, peak fever, wheezing and rash, oxygen therapy proportion, or second-line anti-MP drug usage. No significant differences were observed between the two groups in the WBC, ESR, LDH, D-dimer, albumin, ALT, ferritin levels, incidence of atelectasis, pleural effusion, or bronchoscopy findings.</p><p><strong>Conclusion: </strong>Co-infection with HAdV can exacerbate the condition of children with MP lobar pneumonia and increase treatment difficulty. Higher MP mutation sequence ratios are associated with more severe airway mucosal damage, and higher HAdV viral loads correlate with more severe disease.</p>","PeriodicalId":11782,"journal":{"name":"European Journal of Clinical Microbiology & Infectious Diseases","volume":" ","pages":"2331-2341"},"PeriodicalIF":3.0000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical analysis of Mycoplasma pneumoniae pneumonia combined with adenovirus infection in children with lobar pneumonia.\",\"authors\":\"Meiying Piao, Na Liu, Fanyang Meng, Hang Liang\",\"doi\":\"10.1007/s10096-025-05194-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Mycoplasma pneumoniae (MP) is a major pathogen that causes community-acquired pneumonia in children with a high rate of co-infection. Human adenovirus (HAdV) is a common co-infecting pathogen. This study aimed to analyze the clinical characteristics of children with lobar pneumonia caused by co-infection with MP and HAdV, and to investigate the correlation between the MP mutation sequence ratio (mutation depth/MP count) and HAdV sequence count with disease severity, thus providing evidence for clinical diagnosis and treatment.</p><p><strong>Methods: </strong>Children with MP-infected lobar pneumonia hospitalized in the Department of Pediatric Respiratory Medicine at the First Hospital of Jilin University from September to November 2023 were enrolled in this study and divided into MP and MP + HAdV groups. Clinical manifestations, laboratory examinations, and treatments were compared between the two groups. Correlations of the MP mutation sequence ratio and HAdV sequence count with clinical manifestations, laboratory examinations, and treatments were analyzed.</p><p><strong>Results: </strong>A total of 154 children with MP lobar pneumonia were included, with 96 cases in the MP group and 58 cases in the MP + HAdV group. The results showed that the MP + HAdV group had a longer total disease duration, fever duration, intravenous anti-MP drug administration duration, and systemic corticosteroid application duration, with a higher proportion of intravenous immunoglobulin use. The MP group had higher CRP levels and a higher incidence of pulmonary necrosis. After 10 days of treatment, the MP group showed better improvement in the pneumonia volume than the MP + HAdV group. There were no significant differences between the two groups in the length of hospital stay, peak fever, wheezing and rash, oxygen therapy proportion, or second-line anti-MP drug usage. No significant differences were observed between the two groups in the WBC, ESR, LDH, D-dimer, albumin, ALT, ferritin levels, incidence of atelectasis, pleural effusion, or bronchoscopy findings.</p><p><strong>Conclusion: </strong>Co-infection with HAdV can exacerbate the condition of children with MP lobar pneumonia and increase treatment difficulty. Higher MP mutation sequence ratios are associated with more severe airway mucosal damage, and higher HAdV viral loads correlate with more severe disease.</p>\",\"PeriodicalId\":11782,\"journal\":{\"name\":\"European Journal of Clinical Microbiology & Infectious Diseases\",\"volume\":\" \",\"pages\":\"2331-2341\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Clinical Microbiology & Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s10096-025-05194-6\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/26 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Clinical Microbiology & Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10096-025-05194-6","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/26 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

摘要

目的:肺炎支原体(Mycoplasma pneumoniae, MP)是引起儿童社区获得性肺炎的主要病原菌,合并感染率较高。人腺病毒是一种常见的共感染病原体。本研究旨在分析小儿大叶性肺炎合并MP和hav感染的临床特点,探讨MP突变序列比(突变深度/MP计数)和hav序列计数与疾病严重程度的相关性,为临床诊断和治疗提供依据。方法:选取吉林大学第一医院2023年9 - 11月儿科呼吸内科住院的MP感染大叶性肺炎患儿,分为MP组和MP + hav组。比较两组患者的临床表现、实验室检查及治疗方法。分析MP突变序列率和hav序列数与临床表现、实验室检查和治疗的相关性。结果:共纳入MP大叶性肺炎患儿154例,其中MP组96例,MP + hav组58例。结果显示,MP + hav组总病程、发热时间、静脉抗MP药物给药时间、全身皮质类固醇应用时间更长,静脉免疫球蛋白使用比例更高。MP组CRP水平较高,肺坏死发生率较高。治疗10 d后,MP组肺炎体积的改善优于MP + hav组。两组患者在住院时间、高热、喘鸣和皮疹、氧疗比例、二线抗mp药物使用等方面无显著差异。两组在WBC、ESR、LDH、d -二聚体、白蛋白、ALT、铁蛋白水平、肺不张发生率、胸腔积液或支气管镜检查结果方面均无显著差异。结论:乙型肝炎合并感染可加重小儿大叶性肺炎病情,增加治疗难度。较高的MP突变序列比与更严重的气道黏膜损伤相关,较高的hav病毒载量与更严重的疾病相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Clinical analysis of Mycoplasma pneumoniae pneumonia combined with adenovirus infection in children with lobar pneumonia.

Objective: Mycoplasma pneumoniae (MP) is a major pathogen that causes community-acquired pneumonia in children with a high rate of co-infection. Human adenovirus (HAdV) is a common co-infecting pathogen. This study aimed to analyze the clinical characteristics of children with lobar pneumonia caused by co-infection with MP and HAdV, and to investigate the correlation between the MP mutation sequence ratio (mutation depth/MP count) and HAdV sequence count with disease severity, thus providing evidence for clinical diagnosis and treatment.

Methods: Children with MP-infected lobar pneumonia hospitalized in the Department of Pediatric Respiratory Medicine at the First Hospital of Jilin University from September to November 2023 were enrolled in this study and divided into MP and MP + HAdV groups. Clinical manifestations, laboratory examinations, and treatments were compared between the two groups. Correlations of the MP mutation sequence ratio and HAdV sequence count with clinical manifestations, laboratory examinations, and treatments were analyzed.

Results: A total of 154 children with MP lobar pneumonia were included, with 96 cases in the MP group and 58 cases in the MP + HAdV group. The results showed that the MP + HAdV group had a longer total disease duration, fever duration, intravenous anti-MP drug administration duration, and systemic corticosteroid application duration, with a higher proportion of intravenous immunoglobulin use. The MP group had higher CRP levels and a higher incidence of pulmonary necrosis. After 10 days of treatment, the MP group showed better improvement in the pneumonia volume than the MP + HAdV group. There were no significant differences between the two groups in the length of hospital stay, peak fever, wheezing and rash, oxygen therapy proportion, or second-line anti-MP drug usage. No significant differences were observed between the two groups in the WBC, ESR, LDH, D-dimer, albumin, ALT, ferritin levels, incidence of atelectasis, pleural effusion, or bronchoscopy findings.

Conclusion: Co-infection with HAdV can exacerbate the condition of children with MP lobar pneumonia and increase treatment difficulty. Higher MP mutation sequence ratios are associated with more severe airway mucosal damage, and higher HAdV viral loads correlate with more severe disease.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
10.40
自引率
2.20%
发文量
138
审稿时长
1 months
期刊介绍: EJCMID is an interdisciplinary journal devoted to the publication of communications on infectious diseases of bacterial, viral and parasitic origin.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信